Biohaven
Biohaven

Dividends • Biohaven

BHVN

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
3/27/2024
4/12/2024
0,285
Quarterly
3/14/2024
3/29/2024
0,23
Quarterly
12/28/2023
1/12/2024
0,285
Quarterly
12/14/2023
12/29/2023
0,23
Quarterly
9/28/2023
10/13/2023
0,28
Quarterly
9/14/2023
9/29/2023
0,23
Quarterly
6/29/2023
7/14/2023
0,28
Quarterly
6/15/2023
6/30/2023
0,23
Quarterly
3/30/2023
4/14/2023
0,275
Quarterly
3/16/2023
3/31/2023
0,23
Quarterly